A once-dismissed idea that a single pill could stop cancer now shapes how doctors treat the disease.
This week, Oregon Health & Science University honored Dr. Brian Druker, the physician-scientist who helped prove it.
University leaders awarded Druker, who developed the leukemia drug Gleevec, the inaugural Knight Lifetime Achievement Award. The honor marks the 25th anniversary of the drug’s federal approval and its role in transforming cancer care…